Have a feature idea you'd love to see implemented?
Let us know!
TNDM Tandem Diabetes Care Inc
Price (delayed)
$31.76
Market cap
$2.08B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.09
Enterprise value
$2.51B
Tandem Diabetes Care is a public US medical device manufacturer based in San Diego, CA. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.
Highlights
Tandem Diabetes Care's EPS has increased by 40% YoY and by 3.7% from the previous quarter
The net income has increased by 39% YoY and by 3.5% from the previous quarter
Tandem Diabetes Care's gross profit has decreased by 3.5% YoY but it has increased by 2.9% from the previous quarter
Tandem Diabetes Care's quick ratio has decreased by 34% YoY and by 21% from the previous quarter
The company's equity fell by 29% YoY and by 3.8% QoQ
Key stats
What are the main financial stats of TNDM
Market
Valuations
Earnings
Shares outstanding
65.46M
Market cap
$2.08B
Enterprise value
$2.51B
Price to earnings (P/E)
N/A
Price to book (P/B)
8.77
Price to sales (P/S)
2.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.15
Revenue
$796M
EBIT
-$120.98M
EBITDA
-$104.77M
Free cash flow
-$41.95M
Per share
Balance sheet
Liquidity
EPS
-$2.09
Free cash flow per share
-$0.65
Book value per share
$3.62
Revenue per share
$12.25
TBVPS
$14.42
Total assets
$937.5M
Total liabilities
$703.63M
Debt
$477.11M
Equity
$233.88M
Working capital
$492.78M
Debt to equity
2.04
Current ratio
3.05
Quick ratio
2.29
Net debt/EBITDA
-4.1
Margins
Efficiency
Dividend
EBITDA margin
-13.2%
Gross margin
49.1%
Net margin
-17.1%
Operating margin
-17.5%
Return on assets
-14.5%
Return on equity
-49.4%
Return on invested capital
-10.8%
Return on capital employed
-17.4%
Return on sales
-15.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TNDM stock price
How has the Tandem Diabetes Care stock price performed over time
Intraday
-1.21%
1 week
-8.76%
1 month
-30.11%
1 year
66.46%
YTD
7.37%
QTD
-25.11%
Financial performance
How have Tandem Diabetes Care's revenue and profit performed over time
Revenue
$796M
Gross profit
$390.51M
Operating income
-$139.06M
Net income
-$136.49M
Gross margin
49.1%
Net margin
-17.1%
The net margin has increased by 40% YoY and by 7% from the previous quarter
The operating margin has grown by 40% YoY and by 8% from the previous quarter
The operating income rose by 40% YoY and by 5% QoQ
The net income has increased by 39% YoY and by 3.5% from the previous quarter
Growth
What is Tandem Diabetes Care's growth rate over time
Valuation
What is Tandem Diabetes Care stock price valuation
P/E
N/A
P/B
8.77
P/S
2.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.15
Tandem Diabetes Care's EPS has increased by 40% YoY and by 3.7% from the previous quarter
TNDM's price to book (P/B) is 35% less than its 5-year quarterly average of 13.5 but 12% more than its last 4 quarters average of 7.8
The company's equity fell by 29% YoY and by 3.8% QoQ
The P/S is 66% lower than the 5-year quarterly average of 7.6 and 4.1% lower than the last 4 quarters average of 2.7
TNDM's revenue is up by 3.4% since the previous quarter
Efficiency
How efficient is Tandem Diabetes Care business performance
Tandem Diabetes Care's ROS has increased by 44% YoY and by 7% from the previous quarter
The return on invested capital has increased by 44% year-on-year and by 5% since the previous quarter
The return on assets has increased by 35% year-on-year and by 3.3% since the previous quarter
TNDM's ROE is up by 16% YoY but it is down by 4.7% from the previous quarter
Dividends
What is TNDM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TNDM.
Financial health
How did Tandem Diabetes Care financials performed over time
The total assets is 33% greater than the total liabilities
Tandem Diabetes Care's quick ratio has decreased by 34% YoY and by 21% from the previous quarter
TNDM's current ratio is down by 30% year-on-year and by 20% since the previous quarter
The debt is 104% more than the equity
The company's debt to equity has surged by 59% YoY and by 4.1% QoQ
The company's equity fell by 29% YoY and by 3.8% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.